Bentham Science Central Nervous System Collection

THE COLLECTION INCLUDE ARTICLES FROM THESE JOURNALS

 

     

and many more Books…

✔ 130 Journals

✔ 7 Book Series

✔ 45 Books in Total 

 

FEATURES AND BENEFITS: 

♦ Access to over 11,000 scholarly articles covering several aspects of Central Nervous System

♦ Contents come from more than 100 Bentham Science Journals (40 journals indexed in JCR 2017 with impact factor rankings)

♦ Includes both; Original Research and Review Articles

♦ Research from leading institutions in USA, EUROPE, AUSTRALIA, JAPAN, CHINA and other regions

♦ Suitable for researchers in industry and academia wishing to keep updated with latest developments

♦ Easy access to institutions and individuals through IP-based authentication

♦ Access new Neuroscience Research included in this collection as soon as it is published

 

FLEXIBLE PACKAGES 

Over 950 articles from 2018

Over 2,764 articles from the last 3 years

More than 9,000 articles from the last 10 years

 

Annual addition of over 1,000 new Central Nervous System related articles each year

Tailor-made packages available for pharmaceuticals companies, research institutes, universities, hospitals, clinical/academic societies, and corporations.

 

You can also send your librarian’s contact information to us at marketing@benthamscience.net  CC: hermain@benthamscience.net

 

 

To learn more about our Central Nervous System Collection, please visit  our website: http://bit.ly/2tOEZRo

New Issue | Central Nervous System Agents in Medicinal Chemistry; Volume 19 Issue 2

 

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Containing a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics, Central Nervous System Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.

 

Articles from the journal: Central Nervous System Agents in Medicinal Chemistry; Volume 19 Issue 2:

• Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review open access plus
• Acrylamide Induced Toxicity and the Propensity of Phytochemicals in Amelioration: A Review
• Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
• Aging Affects Nicotinic Acetylcholine Receptors in Brain
• Pharmacological Approach of Pistacia Vera Fruit to Assess Learning and Memory Potential in Chemically-Induced Memory Impairment in Mice
• Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase open access plus
• Glacial Acetic Acid Catalyzed Synthesis, Physicochemical and Biological Evaluation of Benzodiazepines as Potent CNS Agents

 

 

For details on the articles, please visit this link: http://www.eurekaselect.com/node/613/central-nervous-system-agents-in-medicinal-chemistry-/issue/19/2536/2/9203

RECENTLY PUBLISHED ISSUES – BENTHAM SCIENCE JOURNALS

Reviews on Recent Clinical Trials Volume 13, Issue 1
http://bit.ly/2BEm6T8

Central Nervous System Agents in Medicinal Chemistry Volume 18, Issue 1
http://bit.ly/2ohkDtE

Drug Delivery Letters Volume 8, Issue 1
http://bit.ly/2sK71wE

Current Nanoscience Volume 14, Issue 2
http://bit.ly/2EFSs2A

Current Nanomedicine Volume 8, Issue 1
http://bit.ly/2FgGuth

Current Gene Therapy Volume 17, Issue 5
http://bit.ly/2EFzFnY

Nanoscience & Nanotechnology-Asia Volume 8, Issue 1
http://bit.ly/2oiZsrl

Adolescent Psychiatry Volume 7, Issue 2
http://bit.ly/2HuVBAj

New Issue :: Central Nervous System Agents in Medicinal Chemistry 17, Issue 1

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Containing a series of timely in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics, Central Nervous System Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.

Articles from the journal Central Nervous System Agents in Medicinal Chemistry 17, Issue 1:

• Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
• Thiazolidine: A Potent Candidate for Central Nervous System Diseases
• Drug Design Strategies for the Discovery of Novel Anticonvulsants Concerned with Four Site Binding Pharmacophoric Model Studies
• Psychomotor Seizure Screening and in vitro Neuroprotection Assay of Hydrazones Derived from 2-Acetyl Thiophene
• Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors
• Novel Pyrimidine based Semicarbazones: Confirmation of Four Binding Site Pharmacophoric Model Hypothesis for Antiepileptic Activity
• Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study
• Physiological Targets for the Treatment of Diabetic Encephalopathy

         For details on the articles, please visit this link :: http://bit.ly/2nNp6U4

 

 

 

 

Press Release for EurekAlert! Schiff bases of benzothiazol-2-ylamine and thiazolo[5,4-b] pyridin-2-ylamine

A series of Schiff bases of benzothiazol-2-ylamine/thiazolo [5, 4-b] pyridin-2-ylamine was synthesized. Aniline/4-aminopyridine was converted to the corresponding thiourea derivative, which was then cyclized to obtain benzothiazol-2-ylamine/thiazolo [5, 4-b] pyridin-2-ylamine. Finally, these were condensed with various aromatic and heteroaromatic aldehydes to obtain twelve novel Schiff bases of benzothiazol-2-ylamine and thiazolo [5, 4-b] pyridin-2-ylamine.

The synthesized compounds were characterized by spectral analysis and screened for their anticonvulsant activity using the maximal electroshock (MES) test and isoniazid (INH) induced convulsions test, with phenytoin and diazepam respectively, as the standard drugs. The majority of the compounds were more potent against MES induced convulsions than INH induced convulsions. The relationship between the synthesized compounds and the log P values was also studied, which revealed that the higher the value the better the activity. Schiff bases of benzothiazol-2-ylamine were more effective than thiazolo [5, 4-b] pyridin-2-ylamine against MES induced convulsions. The compound benzothiazol-2-yl-(1H-indol-2-ylmethylene)-amine was the most potent member of the series against both types of convulsions. All the synthesized compounds were predicted to be non-toxic by in-silico toxicity profiling through the Lazar and Osiris properties explorer. Thus, it may be concluded that the Schiff bases of benzothiazol-2-ylamine exhibit the potential to be promising and non-toxic anticonvulsant agents.

Reference: Shukla, R.; et al (2016). Schiff Bases of Benzothiazol-2-ylamine and Thiazolo[5,4-b] pyridin-2-ylamine as Anticonvulsants: Synthesis, Characterization and Toxicity Profiling. Central Nervous System Agents in Medicinal Chemistry., DOI: 10.2174/1871524916666160428110728

For more information about the article, please visit: http://benthamscience.com/journals/central-nervous-system-agents-in-medicinal-chemistry/volume/16/issue/3/page/240/

Highlighted Article Flyer for the journal “Central Nervous System Agents in Medicinal Chemistry”

http://benthamscience.com/journals/central-nervous-system-agents-in-medicinal-chemistry/

Wishing A Very Happy Birthday To Dr. Gregory S.Hamilton!

Dr. Gregory S. Hamilton

Editor-in-Chief: Central Nervous System Agents in Medicinal Chemistry

Office of Law and Government Affairs,

Intellectual Property Eisai Inc.,

6611 Tributary Street, Baltimore, MD 21224T